SPECTRAL AI, INC. Increase (Decrease) in Unbilled Receivables
SPECTRAL AI, INC. (MDAI) reported Increase (Decrease) in Unbilled Receivables of -$618.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2024-05-09
- SPECTRAL AI, INC. increase (decrease) in unbilled receivables for the quarter ending 2023-12-31 was -$127.00K.
- SPECTRAL AI, INC. increase (decrease) in unbilled receivables for the quarter ending 2023-09-30 was $36.00K, a 95.62% decline year-over-year.
- SPECTRAL AI, INC. increase (decrease) in unbilled receivables for the quarter ending 2023-06-30 was -$297.00K.
- SPECTRAL AI, INC. increase (decrease) in unbilled receivables for the quarter ending 2023-03-31 was -$230.00K.
- SPECTRAL AI, INC. increase (decrease) in unbilled receivables for fiscal 2023 was -$618.00K, a 212.98% decline from fiscal 2022.
- SPECTRAL AI, INC. increase (decrease) in unbilled receivables for fiscal 2022 was $547.00K.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$91.00K derived: sum of 2 quarters · filed 2024-03-29 | -$388.00K derived: sum of 3 quarters · filed 2024-03-29 | -$618.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $36.00K derived: 10-Q 9 month − 8-K 6 month · filed 2023-11-14 | -$261.00K derived: sum of 2 quarters · filed 2023-11-14 | -$491.00K 10-Q · filed 2023-11-14 | -$1.45M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | -$297.00K derived: 8-K 6 month − 10-Q 3 month · filed 2023-09-15 | -$527.00K 8-K · filed 2023-09-15 | -$1.48M derived: sum of 3 quarters · filed 2024-05-09 | -$661.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | -$230.00K 10-Q · filed 2024-05-09 | -$1.19M derived: sum of 2 quarters · filed 2024-05-09 | -$364.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$134.00K derived: sum of 2 quarters · filed 2024-03-29 | $547.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $821.00K derived: 10-Q 9 month − 8-K 6 month · filed 2023-11-14 | $1.50M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $681.00K 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |